LUP Statistics
Record
- Title
- SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
- Type
- Journal Article
- Publ. year
- 2013
- Author/s
- Hansen, Nils; Ågerstam, Helena; Wahlestedt, Martin; Landberg, Niklas et al.
- Department/s
- Division of Clinical Genetics; Department of Experimental Medical Science; Tumor microenvironment; Family Medicine and Clinical Epidemiology; StemTherapy: National Initiative on Stem Cells for Regenerative Therapy; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 428 | 11 | 2 |
United States of America  |
224 (52%) |
Germany  |
61 (14%) |
China  |
42 (10%) |
Sweden  |
23 (5%) |
Czechia  |
14 (3%) |
Russian Federation  |
11 (3%) |
France  |
6 (1%) |
Denmark  |
5 (1%) |
United Kingdom of Great Britain and Northern Ireland  |
4 (1%) |
Netherlands (Kingdom of the)  |
4 (1%) |
Hong Kong (China)  |
4 (1%) |
Ukraine  |
3 (1%) |
South Korea  |
3 (1%) |
Spain  |
2 (0%) |
Portugal  |
2 (0%) |
Italy  |
2 (0%) |
Iraq  |
2 (0%) |
Canada  |
2 (0%) |
Latvia  |
1 (0%) |
Switzerland  |
1 (0%) |
Singapore  |
1 (0%) |
Egypt  |
1 (0%) |
Unknown  |
1 (0%) |
Poland  |
1 (0%) |
Brazil  |
1 (0%) |
European Union location  |
1 (0%) |
Hungary  |
1 (0%) |
Romania  |
1 (0%) |
Japan  |
1 (0%) |
Kazakhstan  |
1 (0%) |
Indonesia  |
1 (0%) |